The artemisinin (ART)-based antimalarials have contributed significantly to reducing global
malaria deaths over the past decade, but we still do not know how they kill parasites. To gain …

There is a rapidly expanding literature on the in vitro antiviral activity of drugs that may be
repurposed for therapy or chemoprophylaxis against severe acute respiratory syndrome‐…

Atovaquone is used as a fixed-dose combination with proguanil (Malarone) for treating children
and adults with uncomplicated malaria or as chemoprophylaxis for preventing malaria in …

There is an urgent need for new antimalarial drugs with novel mechanisms of action to deliver
effective control and eradication programs. Parasite resistance to all existing antimalarial …

This study reports on the first characterization of the alternative NADH:dehydrogenase (also
known as alternative complex I or type II NADH:dehydrogenase) of the human malaria …

Objectives Artemisinin and artemisinin semi-synthetic derivatives (collectively known as
endoperoxides) are first-line antimalarials for the treatment of uncomplicated and severe malaria…

Primaquine (PQ) is an essential antimalarial drug but despite being developed over 70 years
ago, its mode of action is unclear. Here, we demonstrate that hydroxylated-PQ metabolites (…

The cytochrome bc 1 complex is a key mitochondrial enzyme that catalyses transfer of electrons
maintaining the membrane potential of mitochondria. Currently, atovaquone is the only …

Cytochrome bc 1 is a proven drug target in the prevention and treatment of malaria. The rise
in drug-resistant strains of Plasmodium falciparum, the organism responsible for malaria, …

A program was undertaken to identify hit compounds against NADH:ubiquinone oxidoreductase
(PfNDH2), a dehydrogenase of the mitochondrial electron transport chain of the malaria …